株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

プロテオミクスの世界市場 - 製品・用途・技術・地域別:市場分析・シェア・動向・規模・予測

Proteomics Market, By Product (Reagents, Instruments, and Services), By Application (Clinical Diagnostics, and Drug Discovery), By Technology and Geography (NA, EU, APAC, and RoW) - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025

発行 AnalystView Market Insights 商品コード 796146
出版日 ページ情報 英文 195 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=106.08円で換算しております。
Back to Top
プロテオミクスの世界市場 - 製品・用途・技術・地域別:市場分析・シェア・動向・規模・予測 Proteomics Market, By Product (Reagents, Instruments, and Services), By Application (Clinical Diagnostics, and Drug Discovery), By Technology and Geography (NA, EU, APAC, and RoW) - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025
出版日: 2018年12月24日 ページ情報: 英文 195 Pages
概要

当レポートでは、世界のプロテオミクス市場について分析し、市場の定義や基本構造、主な市場促進・抑制要因、業界の競争力・求心力、市場シェア構造、製品種類別・用途別・技術別・地域別の市場動向見通し (過去4年間・今後8年間分)、主要企業のプロファイルなどについて調査しております。

第1章 プロテオミクス市場:概要

第2章 エグゼクティブ・サマリー

第3章 プロテオミクス市場:主な市場動向

  • 市場促進要因
    • 促進要因の影響度
  • 市場抑制要因
    • 抑制要因の影響度
  • 市場機会
  • 市場の将来動向

第4章 プロテオミクス市場:産業分析

  • ポーターのファイブフォース分析
  • 市場求心力の分析
  • 規制体制の分析

第5章 プロテオミクスの市場環境

  • 市場シェア分析

第6章 プロテオミクス市場:製品別

  • 概要
  • 試薬
    • 概要
    • 市場分析・予測、年間成長率 (金額ベース、通算12年間分)
  • 分析装置
  • サービス

第7章 プロテオミクス市場:用途別

  • 概要
  • 臨床診断
  • 創薬
  • その他

第8章 プロテオミクス市場:技術別

  • 概要
  • 分光法
  • X線結晶解析
  • マイクロアレイ機器
  • 電気泳動
  • タンパク質分画装置
  • 表面プラズマ共鳴 (SPR) システム

第9章 プロテオミクス市場:地域別

  • イントロダクション
  • 北米市場 (米国、カナダ)
    • 概要
    • 市場規模の分析・予測、年間成長率 (金額ベース、通算12年間分)
    • 国別分析
  • 欧州市場 (フランス、ドイツなど)
  • アジア太平洋地域市場 (中国、インドなど)
  • 他の国々の市場 (RoW:ラテンアメリカ、中東・アフリカ)

第10章 主要ベンダーの分析

  • Agilent Technologies
    • 企業概要
    • SWOT分析
    • 近年の主な動向
  • Bio-Rad Laboratories
  • GE Healthcare
  • Roche Diagnostics
  • Sigma - Aldrich
  • Illumina, Inc.

第11章 アナリストの全方位的分析

第12章 付録

図表

List of Tables

  • Table 1: List of Acronyms
  • Table 2: Key Market Facts, 2014 - 2025
  • Table 3: Market Drivers: Impact Analysis
  • Table 4: Market Restraint: Impact Analysis
  • Table 5: Market Opportunity: Impact Analysis
  • Table 6: PEST Analysis
  • Table 7: Porter's Five Forces Analysis
  • Table 8: Company Market Share Analysis
  • Table 9: Global Proteomics Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • Table 10: Proteomics Market, by Product, 2014 - 2025 (USD Billion)
  • Table 11: Proteomics Market, by Application, 2014 - 2025 (USD Billion)
  • Table 12: Proteomics Market, by Technology, 2014 - 2025 (USD Billion)
  • Table 13: Proteomics Market, by Geography, 2014 - 2025 (USD Billion)
  • Table 14: North America Proteomics Market, 2014 - 2025 (USD Billion)
  • Table 15: U.S. Proteomics Market, 2014 - 2025 (USD Billion)
  • Table 16: Canada Proteomics Market, 2014 - 2025 (USD Billion)
  • Table 17: Europe Proteomics Market, 2014 - 2025 (USD Billion)
  • Table 18: France Proteomics Market, 2014 - 2025 (USD Billion)
  • Table 19: Germany Proteomics Market, 2014 - 2025 (USD Billion)
  • Table 20: Asia Pacific Proteomics Market, 2014 - 2025 (USD Billion)
  • Table 21: China Proteomics Market, 2014 - 2025 (USD Billion)
  • Table 22: India Proteomics Market, 2014 - 2025 (USD Billion)
  • Table 23: Latin America Proteomics Market, 2014 - 2025 (USD Billion)
  • Table 24: MEA Proteomics Market, 2014 - 2025 (USD Billion)

List of Figures

  • Figure 1: Research Methodology
  • Figure 2: Research Process Flow Chart
  • Figure 3: Comparative Analysis, by Geography, 2016-2025 (Value %)
  • Figure 4: Regulatory Framework Analysis
  • Figure 5: Proteomics Market, by Product, 2014 - 2025 (USD Billion)
  • Figure 6: Proteomics Market, by Application, 2014 - 2025 (USD Billion)
  • Figure 7: Proteomics Market, by Technology, 2014 - 2025 (USD Billion)
  • Figure 8: Proteomics Market, by Geography, 2014 - 2025 (USD Billion)
目次

REPORT HIGHLIGHT

The proteomics market is estimated to represent a global market of USD 13.4 billion by 2017 with growth rate of 10.2%.

Market Dynamics

Proteomics is defined as the large-scale study of protein molecules particularly their structures, composition, interactions, and functions. It represents the complete set of the protein encoded by the genome. This study helps in understanding the structure and function of different proteins and alteration in protein expressions during stress condition or different stages of the life cycle. Proteomics technique provides a clear understanding of the organism rather than genomics. Further, as protein molecules are the most favorable targets for therapeutics, detailed analysis of proteins offers great opportunities for the drug development and biological processes. Thereby, after genomics, this biological discipline is usually considered as the advanced step during the study of biological systems. Based on the protein response, this technique is classified into structural, expression, and functional proteomics. Factors such as favorable government initiatives for proteomic research and growing importance among public funding institutions bode well for the worldwide proteomics market.

However, it is noted that this biological discipline inherently demands huge capital investments and historically, the investment has yielded poor revenues. Thus, despite these growth opportunities, low return on investment can dissuade companies in adopting proteomics technologies for drug developments. In addition to this, strict regulatory approvals and the high cost of instruments act as a potential barrier for this industry growth.

Product Takeaway

Product segment is categorized as Reagents, Instruments, and Services. Reagent accounted for over 30% industry share, comprise of electrophoresis kits, sample kits, purification kits among others. Application segment is bifurcated into Clinical Diagnostics, Drug Discovery, and others. This technology is widely used in clinical diagnostics and therapeutics development, mainly applied in tumor biology, and biomedicine.

Technology Takeaway

Depending upon technology, the market is bifurcated as Spectroscopy, X-Ray Crystallography, Microarray Instruments, Electrophoresis, Protein Fractionation Systems, and Surface Plasma Resonance (SPR) Systems. Of these, electrophoresis and microarray Instruments accounted for the significant revenue share. 2DE (Two-dimensional electrophoresis) is considered to be the most cost-effective protein profiling technologies.

Regional Takeaway

Regionally, the market is classified as North America, Europe, Asia Pacific and Rest of the World. With the highest share, North America surfaced up as ruling party for proteomics market, followed by Europe. Increasing interest in integrated technologies is supporting the rapid expansion of protein biochip and bio-informatics technologies, establishing a healthy platform for market growth in developed regions. Emerging economies of the Asia Pacific and Latin America set to manifest a higher CAGR, supported by a rising focus on biotech research coupled with the growing outsourcing of proteomics research.

Key Vendor Takeaway

Companies namely Agilent Technologies, Bio-Rad Laboratories, GE Healthcare, Roche Diagnostics, Sigma - Aldrich and Illumina, Inc. are operating in this market. Companies are engaged in introducing new products to capture a large customer base. For instance, in June 2015, Agilent Technologies introduced an updated gene expression microarray for studying the expression of miRNA, mRNA and IncRNA in human, mouse, and rate model.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year - 2014 & 2016

Base Year - 2017

Estimated Year - 2018

Projected Year - 2025

TARGET AUDIENCE:

Traders, Distributors, and Suppliers

Manufacturers

Government and Regional Agencies and Research Organizations

Consultants

Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY PRODUCT

Reagents

Instruments

Services

MARKET, BY APPLICATION

Clinical Diagnostics

Drug Discovery

Others

MARKET, BY TECHNOLOGY

Spectroscopy

X-Ray Crystallography

Microarray Instruments

Electrophoresis

Protein Fractionation Systems

Surface Plasma Resonance (SPR) Systems

MARKET, BY REGION

North America

U.S.

Canada

Europe

Germany

France

Rest of Europe

Asia Pacific

India

China

Rest of APAC

Rest of the World

Middle East and Africa

Latin America

TABLE OF CONTENTS

1. PROTEOMICS MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Key Market Facts
  • 2.2. Geographical Scenario
  • 2.3. Companies in the Market

3. PROTEOMICS KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. PROTEOMICS INDUSTRY STUDY

  • 4.1. Porter's Analysis
  • 4.2. Market Attractiveness Analysis
  • 4.3. Regulatory Framework Analysis

5. PROTEOMICS MARKET LANDSCAPE

  • 5.1. Market Share Analysis

6. PROTEOMICS MARKET - BY PRODUCT

  • 6.1. Overview
  • 6.2. Reagents
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 6.3. Instruments
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 6.4. Services
    • 6.4.1. Overview
    • 6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)

7. PROTEOMICS MARKET - BY APPLICATION

  • 7.1. Overview
  • 7.2. Clinical Diagnostics
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 7.3. Drug Discovery
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 7.4. Others
    • 7.4.1. Overview
    • 7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)

8. PROTEOMICS MARKET - BY TECHNOLOGY

  • 8.1. Overview
  • 8.2. Spectroscopy
    • 8.2.1. Overview
    • 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 8.3. X-Ray Crystallography
    • 8.3.1. Overview
    • 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 8.4. Microarray Instruments
    • 8.4.1. Overview
    • 8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 8.5. Electrophoresis
    • 8.5.1. Overview
    • 8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 8.6. Protein Fractionation Systems
    • 8.6.1. Overview
    • 8.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 8.7. Surface Plasma Resonance (SPR) Systems
    • 8.7.1. Overview
    • 8.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)

9. PROTEOMICS MARKET- BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 9.2.3. U.S.
    • 9.2.3.1. Overview
    • 9.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 9.2.4. Canada
    • 9.2.4.1. Overview
    • 9.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 9.3.3. France
    • 9.3.3.1. Overview
    • 9.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 9.3.4. Germany
    • 9.3.4.1. Overview
    • 9.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 9.3.5. Rest of Europe
    • 9.3.5.1. Overview
    • 9.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 9.4.3. China
    • 9.4.3.1. Overview
    • 9.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 9.4.4. India
    • 9.4.4.1. Overview
    • 9.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 9.4.5. Rest of APAC
    • 9.4.5.1. Overview
    • 9.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 9.5. Rest of the World
    • 9.5.1. Overview
    • 9.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 9.5.3. Latin America
    • 9.5.3.1. Overview
    • 9.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 9.5.4. Middle East and Africa
    • 9.5.4.1. Overview
    • 9.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)

10. KEY VENDOR ANALYSIS

  • 10.1. Agilent Technologies
    • 10.1.1. Company Overview
    • 10.1.2. SWOT Analysis
    • 10.1.3. Key Developments
  • 10.2. Bio-Rad Laboratories
    • 10.2.1. Company Overview
    • 10.2.2. SWOT Analysis
    • 10.2.3. Key Developments
  • 10.3. GE Healthcare
    • 10.3.1. Company Overview
    • 10.3.2. SWOT Analysis
    • 10.3.3. Key Developments
  • 10.4. Roche Diagnostics
    • 10.4.1. Company Overview
    • 10.4.2. SWOT Analysis
    • 10.4.3. Key Developments
  • 10.5. Sigma - Aldrich
    • 10.5.1. Company Overview
    • 10.5.2. SWOT Analysis
    • 10.5.3. Key Developments
  • 10.6. Illumina, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. SWOT Analysis
    • 10.6.3. Key Developments

Client can request additional company profiling as per specific requirements

11. 360 DEGREE ANALYSTVIEW

12. APPENDIX

  • 12.1. Research Methodology
  • 12.2. Abbreviations
  • 12.3. Disclaimer
  • 12.4. Contact Us
Back to Top